These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29119628)

  • 1. STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.
    Assumpção ALFV; Jark PC; Hong CC; Lu Z; Ruetten HM; Heaton CM; Pinkerton ME; Pan X
    J Vet Intern Med; 2018 Jan; 32(1):361-369. PubMed ID: 29119628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.
    Lam LT; Wright G; Davis RE; Lenz G; Farinha P; Dang L; Chan JW; Rosenwald A; Gascoyne RD; Staudt LM
    Blood; 2008 Apr; 111(7):3701-13. PubMed ID: 18160665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases.
    Vajpayee N; Hussain J; Tolocica I; Hutchison RE; Gajra A
    J Neurooncol; 2010 Nov; 100(2):249-53. PubMed ID: 20446017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
    Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
    Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy.
    Curran KM; Schaffer PA; Frank CB; Lana SE; Hamil LE; Burton JH; Labadie J; Ehrhart EJ; Avery PR
    Vet Comp Oncol; 2017 Dec; 15(4):1269-1279. PubMed ID: 27514648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.
    Ma J; Xing W; Coffey G; Dresser K; Lu K; Guo A; Raca G; Pandey A; Conley P; Yu H; Wang YL
    Oncotarget; 2015 Dec; 6(41):43881-96. PubMed ID: 26575169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma.
    Habineza Ndikuyeze G; Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Flood P; Krick E; Propert KJ; Mason NJ
    PLoS One; 2014; 9(5):e95404. PubMed ID: 24798348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma.
    Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG
    Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
    Sun X; Li B; Xie B; Xu Z; Chang G; Tao Y; Zhang Y; Chang S; Wang Y; Yu D; Xie Y; Li T; Wang H; Chen G; Hu L; Hou J; Zhang Y; Xiao W; Gao L; Shi J; Zhu W
    Cell Death Dis; 2017 Oct; 8(10):e3111. PubMed ID: 29022919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
    Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
    Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
    Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.
    Högfeldt T; Johnsson P; Grandér D; Bahnassy AA; Porwit A; Eid S; Österborg A; Zekri AR; Lundahl J; Khaled MH; Mellstedt H; Moshfegh A
    Leuk Lymphoma; 2014 May; 55(5):1158-65. PubMed ID: 23841503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of FoxP3
    Muir CF; Priestnall SL; Hibbert A; Brown C; Garden OA; Scase T
    J Comp Pathol; 2017 Jul; 157(1):15-22. PubMed ID: 28735665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of leptin receptor, p-STAT3 and p-AKT in diffuse large B-cell lymphoma.
    Lin S; YuJun L; XiaoMing X; WenWen R
    Acta Histochem; 2014 Jan; 116(1):126-30. PubMed ID: 24054064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 associated athanogene-1 overexpression in diffuse large B-cell lymphoma.
    Ataollahi M; Salehi M; Doostan I; Kabiri Z; Mohajeri M; Mahmoodi F; Shokouhi R; Javan S; Meshkibaf MH; Miladpoor B
    Iran J Immunol; 2008 Jun; 5(2):124-30. PubMed ID: 18523358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
    Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mutations in the genes involved in Janus kinase/signal transducer and activator of transcription pathway in canine large cell gastrointestinal lymphoma.
    Tsuruta T; Matsumura N; Mizukami K; Goto-Koshino Y; Aoi T; Yamada R; Nagao I; Sakamoto M; Nakagawa T; Fukuoka R; Ohmi A; Chambers JK; Uchida K; Momozawa Y; Tomiyasu H
    J Vet Med Sci; 2024 Oct; 86(10):1052-1055. PubMed ID: 39135232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.
    Zhang Q; Yang Z; Jia Z; Liu C; Guo C; Lu H; Chen P; Ma K; Wang W; Zhou C
    Mol Cancer; 2014 Jul; 13():181. PubMed ID: 25070240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
    Brault L; Menter T; Obermann EC; Knapp S; Thommen S; Schwaller J; Tzankov A
    Br J Cancer; 2012 Jul; 107(3):491-500. PubMed ID: 22722314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.
    Demosthenous C; Han JJ; Hu G; Stenson M; Gupta M
    Oncotarget; 2015 Dec; 6(42):44703-13. PubMed ID: 26565811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.